Battler - thanks for posting the Article.
Dr Levin further enhanced his reputation as a astute playmaker in the Biotech / Pharma space, with his well known "String of Pearls" strategy whilst his time at Bristol-Myers Squibb's , which was aimed to make sequential transactions to secure compounds, pipeline or entire companies to fill specific pipeline gaps.
Here is the reference.
Jeremy Levin - The 25 most influential people in biopharma today.
http://www.fiercebiotech.com/special-reports/25-most-influential-people-biopharma-today/jeremy-levin-25-most-influential-people-b.
Interesting times ahead.
DYOR.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.025(1.47%) |
Mkt cap ! $2.207B | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.73 | $1.64 | $4.189M | 2.480M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31201 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 59276 | 6 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |